rs35719192

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM1BP4_StrongBP6_Very_StrongBS2

The ENST00000295754.10(TGFBR2):​c.1119G>A​(p.Met373Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00171 in 1,608,076 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M373K) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0013 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0017 ( 9 hom. )

Consequence

TGFBR2
ENST00000295754.10 missense

Scores

4
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:1B:26

Conservation

PhyloP100: 3.11
Variant links:
Genes affected
TGFBR2 (HGNC:11773): (transforming growth factor beta receptor 2) The protein encoded by this gene is a transmembrane protein that has a protein kinase domain, forms a heterodimeric complex with TGF-beta receptor type-1, and binds TGF-beta. This receptor/ligand complex phosphorylates proteins, which then enter the nucleus and regulate the transcription of genes related to cell proliferation, cell cycle arrest, wound healing, immunosuppression, and tumorigenesis. Mutations in this gene have been associated with Marfan Syndrome, Loeys-Deitz Aortic Aneurysm Syndrome, and the development of various types of tumors. Alternatively spliced transcript variants encoding different isoforms have been characterized. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -14 ACMG points.

PM1
In a hotspot region, there are 6 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 11 uncertain in ENST00000295754.10
BP4
Computational evidence support a benign effect (MetaRNN=0.009409457).
BP6
Variant 3-30672302-G-A is Benign according to our data. Variant chr3-30672302-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 36859.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-30672302-G-A is described in Lovd as [Likely_benign].
BS2
High AC in GnomAd4 at 199 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TGFBR2NM_003242.6 linkuse as main transcriptc.1119G>A p.Met373Ile missense_variant 4/7 ENST00000295754.10 NP_003233.4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TGFBR2ENST00000295754.10 linkuse as main transcriptc.1119G>A p.Met373Ile missense_variant 4/71 NM_003242.6 ENSP00000295754 P1P37173-1
TGFBR2ENST00000359013.4 linkuse as main transcriptc.1194G>A p.Met398Ile missense_variant 5/81 ENSP00000351905 P37173-2
TGFBR2ENST00000672866.1 linkuse as main transcriptn.2715G>A non_coding_transcript_exon_variant 4/7

Frequencies

GnomAD3 genomes
AF:
0.00131
AC:
200
AN:
152202
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000289
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00340
Gnomad ASJ
AF:
0.00259
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000282
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00169
Gnomad OTH
AF:
0.00430
GnomAD3 exomes
AF:
0.00144
AC:
354
AN:
246454
Hom.:
2
AF XY:
0.00134
AC XY:
178
AN XY:
132926
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.00373
Gnomad ASJ exome
AF:
0.00351
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000142
Gnomad NFE exome
AF:
0.00139
Gnomad OTH exome
AF:
0.00516
GnomAD4 exome
AF:
0.00175
AC:
2544
AN:
1455756
Hom.:
9
Cov.:
34
AF XY:
0.00171
AC XY:
1237
AN XY:
723518
show subpopulations
Gnomad4 AFR exome
AF:
0.000180
Gnomad4 AMR exome
AF:
0.00391
Gnomad4 ASJ exome
AF:
0.00278
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.0000117
Gnomad4 FIN exome
AF:
0.000320
Gnomad4 NFE exome
AF:
0.00193
Gnomad4 OTH exome
AF:
0.00223
GnomAD4 genome
AF:
0.00131
AC:
199
AN:
152320
Hom.:
1
Cov.:
33
AF XY:
0.00134
AC XY:
100
AN XY:
74474
show subpopulations
Gnomad4 AFR
AF:
0.000289
Gnomad4 AMR
AF:
0.00340
Gnomad4 ASJ
AF:
0.00259
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000282
Gnomad4 NFE
AF:
0.00168
Gnomad4 OTH
AF:
0.00425
Alfa
AF:
0.00152
Hom.:
0
Bravo
AF:
0.00149
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.00311
AC:
12
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00163
AC:
14
ExAC
AF:
0.00135
AC:
164
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:26
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:7
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 01, 2023- -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical Center-- -
Likely benign, criteria provided, single submitterclinical testingGeneDxNov 24, 2020This variant is associated with the following publications: (PMID: 17344846, 16928994, 9395234, 23884466, 27153395, 18781618) -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenNov 01, 2024TGFBR2: BS1 -
Familial thoracic aortic aneurysm and aortic dissection Benign:6
Benign, criteria provided, single submitterclinical testingCHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern OntarioMar 25, 2019- -
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsJan 23, 2019This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Likely benign, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthMar 16, 2018- -
Likely benign, criteria provided, single submitterclinical testingCenter for Human Genetics, Inc, Center for Human Genetics, IncNov 01, 2016- -
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
not specified Benign:5
Benign, no assertion criteria providedclinical testingDepartment of Pathology and Laboratory Medicine, Sinai Health System-LB/B > 4 on ClinVar or LB/B > 2 Rep -
Likely benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJun 15, 2011This variant has previously been reported in the literature in an individual wit h clinical features of Loeys-Dietz syndrome; however, the variant was also found in 1/200 control chromosomes (Loeys 2006) and in the reportedly unaffected pare nt of a proband in our laboratory. In addition, this residue is not highly conse rved through different species, which raises the possibility that amino acid cha nges at this position may be tolerated. Therefore, this variant is likely to be benign. -
Benign, criteria provided, single submitterclinical testingMolecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart InstituteJan 14, 2019- -
Likely benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Likely benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Feb 06, 2017- -
Loeys-Dietz syndrome Uncertain:1Benign:2
Benign, no assertion criteria providedclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpFeb 23, 2015- -
Uncertain significance, flagged submissionclinical testingGenomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of PhiladelphiaJun 17, 2015- -
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Marfan syndrome Benign:2
Likely benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Malignant tumor of esophagus;C1860896:Colorectal cancer, hereditary nonpolyposis, type 6;C2674574:Loeys-Dietz syndrome 2 Benign:1
Likely benign, criteria provided, single submitterclinical testingCenter for Genomics, Ann and Robert H. Lurie Children's Hospital of ChicagoMar 30, 2021TGFBR2 NM_003242.5 exon 4 p.Met373Ile (c.1119G>A): This variant has been reported in the literature in one individual with Loeys-Dietz syndrome (Frischmeyer-Guerrerio 2013 PMID:23884466). However, this variant isalso present in 0.3% (47/13666) of Latino alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/3-30672302-G-A?dataset=gnomad_r3) and is present in ClinVar, with several labs classifying this variant as benign or likely benign (Variation ID:36859). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant suggests that this variant does not cause disease, but requires further evidence. Therefore this variant is classified as likely benign. -
Ehlers-Danlos syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenMay 01, 2019- -
Loeys-Dietz syndrome 2 Benign:1
Likely benign, criteria provided, single submitterclinical testingAll of Us Research Program, National Institutes of HealthSep 23, 2024- -
Connective tissue disorder Benign:1
Likely benign, criteria provided, single submitterclinical testingCenter for Human Genetics, Inc, Center for Human Genetics, IncJun 01, 2018- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
21
DANN
Benign
0.95
DEOGEN2
Benign
0.39
T;.
Eigen
Benign
-0.23
Eigen_PC
Benign
-0.036
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Uncertain
0.90
D;D
M_CAP
Benign
0.048
D
MetaRNN
Benign
0.0094
T;T
MetaSVM
Uncertain
-0.27
T
MutationAssessor
Benign
-0.060
N;.
MutationTaster
Benign
0.72
D;D
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
0.34
N;N
REVEL
Benign
0.23
Sift
Benign
0.43
T;T
Sift4G
Benign
0.46
T;T
Polyphen
0.0020
B;.
Vest4
0.11
MutPred
0.31
Loss of glycosylation at P371 (P = 0.0388);.;
MVP
0.94
MPC
0.59
ClinPred
0.015
T
GERP RS
3.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.21
gMVP
0.33

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs35719192; hg19: chr3-30713794; COSMIC: COSV55458038; API